CoChat

Mesenchymal Stem Cells and Induced Bone Marrow-Derived Macrophages Synergistically Improve Liver Fibrosis in Mice

Open access

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Abstract

We describe a novel therapeutic approach for cirrhosis using mesenchymal stem cells (MSCs) and colony-stimulating factor-1-induced bone marrow-derived macrophages (id-BMMs) and analyze the mechanisms underlying fibrosis improvement and regeneration. Mouse MSCs and id-BMMs were cultured from mouse bone marrow and their interactions analyzed in vitro. MSCs, id-BMMs, and a combination therapy using MSCs and id-BMMs were administered to mice with CCl4-induced cirrhosis. Fibrosis regression, liver regeneration, and liver-migrating host cells were evaluated. Administered cell behavior was also tracked by intravital imaging. In coculture, MSCs induced switching of id-BMMs toward the M2 phenotype with high phagocytic activity. In vivo, the combination therapy reduced liver fibrosis (associated with increased matrix metalloproteinases expression), increased hepatocyte proliferation (associated with increased hepatocyte growth factor, vascular endothelial growth factor, and oncostatin M in the liver), and reduced blood levels of liver enzymes, more effectively than MSCs or id-BMMs monotherapy. Intravital imaging showed that after combination cell administration, a large number of id-BMMs, which phagocytosed hepatocyte debris and were retained in the liver for more than 7 days, along with a few MSCs, the majority of which were trapped in the lung, migrated to the fibrotic area in the liver. Host macrophages and neutrophils infiltrated after combination therapy and contributed to liver fibrosis regression and promoted regeneration along with administered cells. Indirect effector MSCs and direct effector id-BMMs synergistically improved cirrhosis along with host cells in mice. These studies pave the way for new treatments for cirrhosis. Stem Cells Translational Medicine 2019;8:271&284

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/sctm.18-0105

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Analysis of mRNA expression changes in mesenchymal stem cells (MSCs) and induced bone marrow‐derived macrophages (id‐BMMs) after addition of serum from mice with CCl4‐induced liver damage to mimic the in vivo microenvironment after cell administration, and after coculture of MSCs and id‐BMMs. Data are presented as the means ± SD, n = 12 in each experiment. (A): mRNA expression changes in MSCs after addition of serum from liver‐damaged mice. Mmp2 (p = .019), Mmp13 (p < .001), Sdf1 (p < .001), Il10 (p < .001), Pge2 (p = .021), Il13 (p < .001), Inos (p < .001), Tnfa (p = .034); upregulated. Timp3 (p < .001); downregulated. (B): mRNA expression changes in id‐BMMs after addition of serum from liver‐damaged mice. Mmp8 (p < .001), Mmp9 (p < .001), Mmp13 (p = .048), Cxcr4 (p < .001), Cxcl1 (p < .001), Cxcl2 (p < .001), Ccl2 (p < .001), Vegf (p < .001), Osm (p < .001), Il10 (p < .001), Fizz1 (p < .001), Ym1 (p = .018), Mrc1 (mannose receptor; p < .001); upregulated. Il6 (p < .001), Tnfa (p < .001), Inos (p = .029); downregulated. (C): mRNA expression changes in id‐BMMs after coculture. Mrc1 (p = .001), Mcp1 (p = .042), Fizz1 (p < .001), Mmp13 (p < .001); upregulated. Ym1 (p = .025), Inos (p < .001), Tnfa (p < .001), Il6 (p < .001); downregulated. (D): mRNA expression change in MSCs after coculture. Tsg6 (p < .001), Pge2 (p < .001); upregulated.
Figure 1 Analysis of mRNA expression changes in mesenchymal stem cells (MSCs) and induced bone marrow‐derived macrophages (id‐BMMs) after addition of serum from mice with CCl4‐induced liver damage to mimic the in vivo microenvironment after cell administration, and after coculture of MSCs and id‐BMMs. Data are presented as the means ± SD, n = 12 in each experiment. (A): mRNA expression changes in MSCs after addition of serum from liver‐damaged mice. Mmp2 (p = .019), Mmp13 (p < .001), Sdf1 (p < .001), Il10 (p < .001), Pge2 (p = .021), Il13 (p < .001), Inos (p < .001), Tnfa (p = .034); upregulated. Timp3 (p < .001); downregulated. (B): mRNA expression changes in id‐BMMs after addition of serum from liver‐damaged mice. Mmp8 (p < .001), Mmp9 (p < .001), Mmp13 (p = .048), Cxcr4 (p < .001), Cxcl1 (p < .001), Cxcl2 (p < .001), Ccl2 (p < .001), Vegf (p < .001), Osm (p < .001), Il10 (p < .001), Fizz1 (p < .001), Ym1 (p = .018), Mrc1 (mannose receptor; p < .001); upregulated. Il6 (p < .001), Tnfa (p < .001), Inos (p = .029); downregulated. (C): mRNA expression changes in id‐BMMs after coculture. Mrc1 (p = .001), Mcp1 (p = .042), Fizz1 (p < .001), Mmp13 (p < .001); upregulated. Ym1 (p = .025), Inos (p < .001), Tnfa (p < .001), Il6 (p < .001); downregulated. (D): mRNA expression change in MSCs after coculture. Tsg6 (p < .001), Pge2 (p < .001); upregulated.CC BY-NC-ND · PubMed Central
Figure 2 Therapeutic effect of mesenchymal stem cells (MSCs) and induced bone marrow‐derived macrophages (id‐BMMs) on CCl4‐induced cirrhosis in mice. (A): The schematic diagram represents the experimental design regarding the induction of fibrosis, cell administration, and analysis in this study. (B, C): Sirius red staining and hydroxyproline assay showing the degree of fibrosis in mice from the control, MSC100, id‐BMM100, and 50/50 groups. Data are presented as the means ± SD, n = 12 mice in each group, p = .315 (hydroxyproline, MSC100), p = .201 (Sirius red, MSC100), p = .006 (hydroxyproline, id‐BMM100), p = .036 (Sirius red, id‐BMM100), p < .001 (hydroxyproline, 50/50), p = .002 (Sirius red, 50/50), compared with control group. (D): Serum levels of ALT, ALP, albumin, and total bilirubin 4 weeks after cell injection. Data are presented as the means ± SD, n = 12 mice in each group, p = .001 (ALT, id‐BMM100), p < .001 (ALT, 50/50), p = .036 (ALP, MSC100), p = .029 (ALP, id‐BMM100), p = .012 (ALP, 50/50), p = .014 (T‐Bil, id‐BMM100), p = .016 (T‐Bil, 50/50), compared with the control group. Scale bar: 100 μm.
Figure 2 Therapeutic effect of mesenchymal stem cells (MSCs) and induced bone marrow‐derived macrophages (id‐BMMs) on CCl4‐induced cirrhosis in mice. (A): The schematic diagram represents the experimental design regarding the induction of fibrosis, cell administration, and analysis in this study. (B, C): Sirius red staining and hydroxyproline assay showing the degree of fibrosis in mice from the control, MSC100, id‐BMM100, and 50/50 groups. Data are presented as the means ± SD, n = 12 mice in each group, p = .315 (hydroxyproline, MSC100), p = .201 (Sirius red, MSC100), p = .006 (hydroxyproline, id‐BMM100), p = .036 (Sirius red, id‐BMM100), p < .001 (hydroxyproline, 50/50), p = .002 (Sirius red, 50/50), compared with control group. (D): Serum levels of ALT, ALP, albumin, and total bilirubin 4 weeks after cell injection. Data are presented as the means ± SD, n = 12 mice in each group, p = .001 (ALT, id‐BMM100), p < .001 (ALT, 50/50), p = .036 (ALP, MSC100), p = .029 (ALP, id‐BMM100), p = .012 (ALP, 50/50), p = .014 (T‐Bil, id‐BMM100), p = .016 (T‐Bil, 50/50), compared with the control group. Scale bar: 100 μm.CC BY-NC-ND · PubMed Central
Figure 3 Analysis of mRNA expression changes for factors related to fibrosis and proregenerative factors at 1, 3, and 7 days after cell administration in the liver, and analysis of the proliferating hepatocytes. (A): mRNA expression changes of factors related to fibrosis (matrix metalloproteinases [MMP] and tissue inhibitor of metalloprotease [TIMP]). Data are presented as the means ± SD, n = 12 in each experiment. Representatively, in the 50/50 group, mRNA levels of MMP‐8 (p < .001; day 3, compared with control, p < .001; day 3, compared with MSC100, p < .001; day 3, compared with id‐BMM100), MMP‐9 (p < .001; day 3, compared with control, p < .001; day 3, compared with MSC100, p < .001; day 3, compared with id‐BMM100), and MMP‐13 (p < .001; day 3, compared with control, p < .001; day 3, compared with MSC100, p < .001; day 3, compared with id‐BMM100) are upregulated, whereas in 50/50 group, mRNA levels of TIMP‐1 (p < .001; day 3, compared with control, p = .001; day 3, compared with MSC100, p < .001; day 3, compared with id‐BMM100), and TIMP‐3 (p < .001; day 3, compared with control, p = .038; day 3, compared with MSC100, p = .029; day 3, compared with id‐BMM100) are downregulated. (B): mRNA expression changes of proregenerative factors (hepatocyte growth factor [HGF], vascular endothelial growth factor [VEGF], and oncostatin M [OSM]). Data are presented as the means ± SD, n = 12 in each experiment. Representatively, in the 50/50 group, mRNA levels of HGF (p < .001; day 7, compared with control, p < .001; day 7, compared with MSC100, p = .003; day 7, compared with id‐BMM100), VEGF (p < .001; day 7, compared with control, p < .001; day 7, compared with MSC100, p < .001; day 7, compared with id‐BMM100), and OSM (p < .001; day 7, compared with control, p < .001; day 7, compared with MSC100, p = .012; day 7, compared with id‐BMM100), are upregulated. (C): Analysis of the proliferating hepatocytes by PCNA staining at day 7 after cell administration. Data are presented as the means ± SD, n = 12 in each experiment, p = .003 (day 7) compared with day 1, p = .001 (day 7) compared with day 3. Scale bar: 100 μm.
Figure 3 Analysis of mRNA expression changes for factors related to fibrosis and proregenerative factors at 1, 3, and 7 days after cell administration in the liver, and analysis of the proliferating hepatocytes. (A): mRNA expression changes of factors related to fibrosis (matrix metalloproteinases [MMP] and tissue inhibitor of metalloprotease [TIMP]). Data are presented as the means ± SD, n = 12 in each experiment. Representatively, in the 50/50 group, mRNA levels of MMP‐8 (p < .001; day 3, compared with control, p < .001; day 3, compared with MSC100, p < .001; day 3, compared with id‐BMM100), MMP‐9 (p < .001; day 3, compared with control, p < .001; day 3, compared with MSC100, p < .001; day 3, compared with id‐BMM100), and MMP‐13 (p < .001; day 3, compared with control, p < .001; day 3, compared with MSC100, p < .001; day 3, compared with id‐BMM100) are upregulated, whereas in 50/50 group, mRNA levels of TIMP‐1 (p < .001; day 3, compared with control, p = .001; day 3, compared with MSC100, p < .001; day 3, compared with id‐BMM100), and TIMP‐3 (p < .001; day 3, compared with control, p = .038; day 3, compared with MSC100, p = .029; day 3, compared with id‐BMM100) are downregulated. (B): mRNA expression changes of proregenerative factors (hepatocyte growth factor [HGF], vascular endothelial growth factor [VEGF], and oncostatin M [OSM]). Data are presented as the means ± SD, n = 12 in each experiment. Representatively, in the 50/50 group, mRNA levels of HGF (p < .001; day 7, compared with control, p < .001; day 7, compared with MSC100, p = .003; day 7, compared with id‐BMM100), VEGF (p < .001; day 7, compared with control, p < .001; day 7, compared with MSC100, p < .001; day 7, compared with id‐BMM100), and OSM (p < .001; day 7, compared with control, p < .001; day 7, compared with MSC100, p = .012; day 7, compared with id‐BMM100), are upregulated. (C): Analysis of the proliferating hepatocytes by PCNA staining at day 7 after cell administration. Data are presented as the means ± SD, n = 12 in each experiment, p = .003 (day 7) compared with day 1, p = .001 (day 7) compared with day 3. Scale bar: 100 μm.CC BY-NC-ND · PubMed Central
Figure 4 Localization of administered mesenchymal stem cells (MSCs) and induced bone marrow‐derived macrophages (id‐BMMs) at 1, 3, and 7 days after cell injection in intravital imaging analysis, and analysis of changes in id‐BMM characteristics. (A): Intravital imaging was performed with two‐photon excitation microscopy of the liver, 3 days after cell administration in the MSC100 (left panels), id‐BMM100 (middle panels), and 50/50 (right panels) groups. Green cells represent administered id‐BMMs, and red cells are administered MSCs. Nuclei were stained with DAPI (blue), and the dense blue area composed of blue fibers represents fibrosis, white dotted lines represent the area of fibrotic liver damage, and white spots represent hepatocyte debris (scale bar: 100 μm). (B, C): Behavior of administered id‐BMMs and MSCs in the liver, lung, and spleen at 1, 3, and 7 days after combination cell administration, n = 12 mice in each group. (D): Representative intravital time‐lapse images of phagocytosis by id‐BMMs. Green cells represent administered id‐BMMs, nuclei are stained with DAPI (blue), the dense blue area composed of blue fibers represents fibrosis, and white spots represent hepatocyte debris (scale bar: left panel, 50 μm; magnified image of left panel, 10 μm), n = 4 mice in each group. (Di): Start point of intravital imaging. (Dii): Three minutes after starting the video, id‐BMMs approached debris. (Diii, Div): After 9–16 minutes, id‐BMMs surrounded, phagocytosed, and digested the debris (phagocytosis activity). (Dv, Dvi): After 21–30 minutes, id‐BMMs reapproached and phagocytosed residual debris. (E): Analysis of changes in id‐BMM characteristics after phagocytosis of hepatocyte debris. mRNA expression changes in id‐BMMs after phagocytosis of hepatocyte debris. Data are presented as the means ± SD, n = 12 in each experiment (Vegf; 3.18‐fold, p < .001, and Osm; 4.25‐fold, p < .001, compared with mRNA levels before phagocytosis).
Figure 4 Localization of administered mesenchymal stem cells (MSCs) and induced bone marrow‐derived macrophages (id‐BMMs) at 1, 3, and 7 days after cell injection in intravital imaging analysis, and analysis of changes in id‐BMM characteristics. (A): Intravital imaging was performed with two‐photon excitation microscopy of the liver, 3 days after cell administration in the MSC100 (left panels), id‐BMM100 (middle panels), and 50/50 (right panels) groups. Green cells represent administered id‐BMMs, and red cells are administered MSCs. Nuclei were stained with DAPI (blue), and the dense blue area composed of blue fibers represents fibrosis, white dotted lines represent the area of fibrotic liver damage, and white spots represent hepatocyte debris (scale bar: 100 μm). (B, C): Behavior of administered id‐BMMs and MSCs in the liver, lung, and spleen at 1, 3, and 7 days after combination cell administration, n = 12 mice in each group. (D): Representative intravital time‐lapse images of phagocytosis by id‐BMMs. Green cells represent administered id‐BMMs, nuclei are stained with DAPI (blue), the dense blue area composed of blue fibers represents fibrosis, and white spots represent hepatocyte debris (scale bar: left panel, 50 μm; magnified image of left panel, 10 μm), n = 4 mice in each group. (Di): Start point of intravital imaging. (Dii): Three minutes after starting the video, id‐BMMs approached debris. (Diii, Div): After 9–16 minutes, id‐BMMs surrounded, phagocytosed, and digested the debris (phagocytosis activity). (Dv, Dvi): After 21–30 minutes, id‐BMMs reapproached and phagocytosed residual debris. (E): Analysis of changes in id‐BMM characteristics after phagocytosis of hepatocyte debris. mRNA expression changes in id‐BMMs after phagocytosis of hepatocyte debris. Data are presented as the means ± SD, n = 12 in each experiment (Vegf; 3.18‐fold, p < .001, and Osm; 4.25‐fold, p < .001, compared with mRNA levels before phagocytosis).CC BY-NC-ND · PubMed Central
Figure 5 Involvement of host macrophages and neutrophils during improvement of liver fibrosis and regeneration. (A, B): Immunostaining for F4/80 and Ly‐6G in the liver, n = 12 for each group. Data are presented as the means ± SD, p < .001 (F4/80, 50/50 compared with control), p < .001 (F4/80, 50/50 compared with MSC100), p = .031 (F4/80, 50/50 compared with id‐BMM100), p < .001 (Ly‐6G, 50/50 compared with control), p = .001 (Ly‐6G, 50/50 compared with MSC100), p = .002 (Ly‐6G, 50/50 compared with id‐BMM100). Scale bar: 100 μm.
Figure 5 Involvement of host macrophages and neutrophils during improvement of liver fibrosis and regeneration. (A, B): Immunostaining for F4/80 and Ly‐6G in the liver, n = 12 for each group. Data are presented as the means ± SD, p < .001 (F4/80, 50/50 compared with control), p < .001 (F4/80, 50/50 compared with MSC100), p = .031 (F4/80, 50/50 compared with id‐BMM100), p < .001 (Ly‐6G, 50/50 compared with control), p = .001 (Ly‐6G, 50/50 compared with MSC100), p = .002 (Ly‐6G, 50/50 compared with id‐BMM100). Scale bar: 100 μm.CC BY-NC-ND · PubMed Central
Figure 6 Host macrophages and neutrophils in the liver. (A, B): Flow cytometric analysis of macrophages (F4/80) and neutrophils (Ly‐6G) in 1 × 106 hematopoietic cells in the liver. The macrophage population contained administered induced bone marrow‐derived macrophages (id‐BMMs; GFP positive cells). Data are presented as the means ± SD, n = 12 mice in each group, p < .001 (macrophages, 50/50 compared with control), p < .001 (macrophages, 50/50 compared with MSC100), p = .004 (macrophages, 50/50 compared with id‐BMM100), p < .001 (neutrophils, 50/50 compared with control), p < .001 (neutrophils, 50/50 compared with MSC100), p = .001 (neutrophils, 50/50 compared with id‐BMM100).
Figure 6 Host macrophages and neutrophils in the liver. (A, B): Flow cytometric analysis of macrophages (F4/80) and neutrophils (Ly‐6G) in 1 × 106 hematopoietic cells in the liver. The macrophage population contained administered induced bone marrow‐derived macrophages (id‐BMMs; GFP positive cells). Data are presented as the means ± SD, n = 12 mice in each group, p < .001 (macrophages, 50/50 compared with control), p < .001 (macrophages, 50/50 compared with MSC100), p = .004 (macrophages, 50/50 compared with id‐BMM100), p < .001 (neutrophils, 50/50 compared with control), p < .001 (neutrophils, 50/50 compared with MSC100), p = .001 (neutrophils, 50/50 compared with id‐BMM100).CC BY-NC-ND · PubMed Central
Figure 7 Schematic representation of the mechanisms underlying the improvement of liver fibrosis and regeneration. (A): Highly enriched mesenchymal stem cells (MSCs) and induced bone marrow‐derived macrophages (id‐BMMs) were cultured from mouse bone marrow in the presence of FGF‐2 and 5% O2 condition, or CSF‐1. (B): After MSCs and id‐BMMs were administered to the mice, the administered cells were activated by cytokines and chemokines in the serum from liver‐damaged mice. (C): Most MSCs migrated to the lung, whereas many id‐BMMs migrated to the liver, and id‐BMMs engrafted near the fibrotic area in the liver. (D): Signals from MSCs that migrated to the lung changed id‐BMMs toward the M2 phenotype, promoting an anti‐inflammatory environment in the liver. (E): Activated id‐BMMs secreted chemoattractant signals in the liver. (F): Endogenous macrophages and neutrophils were recruited from the peripheral blood to the liver by chemoattractant signals. (G): Matrix metalloproteinases secreted from administered id‐BMMs and endogenous cells that migrated to the liver induced regression of fibrosis (antifibrosis). (H): M2 id‐BMMs that gained high phagocytic activity phagocytosed hepatocyte debris more effectively and expressed proregenerative factors (proregeneration).
Figure 7 Schematic representation of the mechanisms underlying the improvement of liver fibrosis and regeneration. (A): Highly enriched mesenchymal stem cells (MSCs) and induced bone marrow‐derived macrophages (id‐BMMs) were cultured from mouse bone marrow in the presence of FGF‐2 and 5% O2 condition, or CSF‐1. (B): After MSCs and id‐BMMs were administered to the mice, the administered cells were activated by cytokines and chemokines in the serum from liver‐damaged mice. (C): Most MSCs migrated to the lung, whereas many id‐BMMs migrated to the liver, and id‐BMMs engrafted near the fibrotic area in the liver. (D): Signals from MSCs that migrated to the lung changed id‐BMMs toward the M2 phenotype, promoting an anti‐inflammatory environment in the liver. (E): Activated id‐BMMs secreted chemoattractant signals in the liver. (F): Endogenous macrophages and neutrophils were recruited from the peripheral blood to the liver by chemoattractant signals. (G): Matrix metalloproteinases secreted from administered id‐BMMs and endogenous cells that migrated to the liver induced regression of fibrosis (antifibrosis). (H): M2 id‐BMMs that gained high phagocytic activity phagocytosed hepatocyte debris more effectively and expressed proregenerative factors (proregeneration).CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

4 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Cited by

See all 161

Metadata

Authors
Watanabe, Y., Tsuchiya, A., Seino, S., Kawata, Y., Kojima, Y., Ikarashi, S., Starkey Lewis, P. J., Lu, W.-Y., Kikuta, J., Kawai, H., Yamagiwa, S., Forbes, S. J., Ishii, M., & Terai, S.
Affiliations
  • Niigata University (JP)
  • b Medical Research Council Centre for Regenerative Medicine The University of Edinburgh, Edinburgh, United Kingdom
  • MRC Centre for Regenerative Medicine (GB)
  • The University of Osaka (JP)
Corresponding author
  • Tsuchiya, Atsunori
  • Terai, Shuji
Venue
Stem Cells Translational Medicine
Published
2018-11-05
Volume
8
Issue
3
Pages
271-284
ISSN
  • 2157-6564 (ISSN-L)
  • 2157-6580
OpenAlex
W2900422864
Cited by
155
References
29
Citations by year
2026: 7 · 2025: 21 · 2024: 13 · 2023: 30 · 2022: 26 · 2021: 27 · 2020: 18 · 2019: 13
FWCI
8.20
Type
journal article
Language
en
Open access
Locations
  • Stem Cells Translational Medicine (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Institutional Repositories DataBase (IRDB) (submittedVersion, cc-by-nc-nd)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion, cc-by-nc-nd)
  • Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by-nc-nd)
Funders
  • Japan Agency for Medical Research and Development (17fk0210101h0001, 16bm0504003h0206)
  • Ministry of Education, Culture, Sports, Science and Technology of Japan
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
Keywords
mesenchymal stem cells, liver fibrosis, liver cirrhosis, M2 macrophage polarization, phagocytosis, hepatocyte regeneration, matrix metalloproteinases, hepatocyte growth factor, oncostatin M, vascular endothelial growth factor, carbon tetrachloride-induced liver injury, intravital imaging, macrophage migration, neutrophil infiltration
MeSH terms
Animals, Cells, Cultured, Disease Models, Animal, Liver, Liver Cirrhosis, Liver Regeneration, Macrophages, Male, Mice, Inbred C57BL, Neutrophils, Hepatocytes, Mesenchymal Stem Cell Transplantation, Cell Proliferation, Mice, Mesenchymal Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.